Market Revenue Cyclospora Diagnostic Testing Industry 2025 | Page 2

Cyclospora Diagnostic Testing Market size on the basis of techniques used for diagnosis spans chromatography,
diagnostic imaging, gel microdroplets, immunoassays, liposomal testing, differential light scattering, flow
cytometry, monoclonal antibodies, and molecular diagnostics.
Cyclospora Diagnostic Testing Market size on the basis of geography spans North America, Asia Pacific, Europe,
and Rest of the World. As far as the geography is concerned, Asia Pacific is lately dominating the Cyclospora
Diagnostic Testing market and it is also recognized as the largest market for these tests owing to more susceptive
surrounding for infection. The data shows that this particular disease is quite prevalent in tropical and
subtropical countries of Latin America and Asia.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/cyclospora-diagnostic-testing-market
In addition, latest irregular occurrence of the infection has also been observed in temperate countries including
the U.S., Canada, and Mexico. The data that has been revealed from the studies of the Centers for Disease
Control and Prevention states that above 600 cases of Cyclospora infection were witnessed in 2013, because of
the infection communicated via the means of packaged salad mix. The key players operating in the cyclospora
diagnostic testing market include Roche Diagnostics, Siemens Healthcare, Diamedix Corporation, Hologic, Inc.,
DiaSorin S.p.A., Thermo Fisher Scientific, Inc., QIAGEN N.V., Wako Chemicals, Inc, Affymetrix, Inc., Nanogen, Inc.,
Ortho Clinical Diagnostics, Beckman Coulter, Inc., bioMerieux, Inc., and CEPHEID.
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/pharmaceuticals